Literature DB >> 16207854

Finding genetic modifiers of cystic fibrosis.

Christina K Haston, Thomas J Hudson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16207854     DOI： 10.1056/NEJMe058185

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

Authors:  G C DeLuca; S V Ramagopalan; B M Herrera; D A Dyment; M R Lincoln; A Montpetit; M Pugliatti; M C N Barnardo; N J Risch; A D Sadovnick; M Chao; S Sotgiu; T J Hudson; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

2.  Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.

Authors:  Rossella Libé; Anelia Horvath; Delphine Vezzosi; Amato Fratticci; Joel Coste; Karine Perlemoine; Bruno Ragazzon; Marine Guillaud-Bataille; Lionel Groussin; Eric Clauser; Marie-Laure Raffin-Sanson; Jennifer Siegel; Jason Moran; Limor Drori-Herishanu; Fabio Rueda Faucz; Maya Lodish; Maria Nesterova; Xavier Bertagna; Jerome Bertherat; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

3.  Identifying modifier loci in existing genome scan data.

Authors:  E W Daw; Y Lu; A J Marian; S Shete
Journal:  Ann Hum Genet       Date:  2008-05-16       Impact factor: 1.670

Review 4.  TGFβ as a therapeutic target in cystic fibrosis.

Authors:  Elizabeth L Kramer; John P Clancy
Journal:  Expert Opin Ther Targets       Date:  2017-12-13       Impact factor: 6.902

5.  Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.

Authors:  Swati Sagwal; Anil Chauhan; Jyotdeep Kaur; Rajendra Prasad; Meenu Singh; Manvi Singh
Journal:  Lung       Date:  2020-01-09       Impact factor: 2.584

6.  Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs.

Authors:  Hongmei Mou; Rui Zhao; Richard Sherwood; Tim Ahfeldt; Allen Lapey; John Wain; Leonard Sicilian; Konstantin Izvolsky; Kiran Musunuru; Chad Cowan; Jayaraj Rajagopal
Journal:  Cell Stem Cell       Date:  2012-04-06       Impact factor: 24.633

7.  Complex two-gene modulation of lung disease severity in children with cystic fibrosis.

Authors:  Ruslan Dorfman; Andrew Sandford; Chelsea Taylor; Baisong Huang; Daisy Frangolias; Yongqian Wang; Richard Sang; Lilian Pereira; Lei Sun; Yves Berthiaume; Lap-Chee Tsui; Peter D Paré; Peter Durie; Mary Corey; Julian Zielenski
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

Authors:  K Czerska; A Sobczynska-Tomaszewska; D Sands; A Nowakowska; D Bak; K Wertheim; J Poznanski; J Zielenski; A Norek; J Bal
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.